- Open
- 1928.00
- High
- 1928.50
- Low
- 1892.50
- Close
- 1901.00
- Change
- -31.00 (-1.61%)
- Volume
- 4,930,806
⌘K
| 1 May 2026 | 15:00:01 | Holding(s) in Company |
| 1 May 2026 | 15:00:00 | Total Voting Rights |
| 29 Apr 2026 | 15:30:00 | Director/PDMR Shareholding |
| 29 Apr 2026 | 07:00:03 | 1st Quarter Results |
| 28 Apr 2026 |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 1 May 2026 | 15:00:01 | Holding(s) in Company |
| 1 May 2026 | 15:00:00 | Total Voting Rights |
| 29 Apr 2026 | 15:30:00 | Director/PDMR Shareholding |
| 29 Apr 2026 | 07:00:03 | 1st Quarter Results |
| 28 Apr 2026 |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 15:30:00 |
| Director/PDMR Shareholding |
Lord Balfe has interests in this issuer
| 15:30:00 |
| Director/PDMR Shareholding |
Lord Balfe has interests in this issuer
